Locations:
Search IconSearch
September 20, 2016/Cancer/News & Insight

ASTRO 2016 – Wednesday, September 28

Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASTRO Annual Meeting

21016-CCCC-ASCO_650x450

Oral Presentations

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

7:45 a.m.

Co-Authors: Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Heron DE

Optimal Treatment Selection of SBRT and IMRT for Re-Irradiation of Head and Neck Cancer: A Multi-Institution Comparison

160 A/B/C

7:55 a.m.

Presenter: Matthew Ward, MD
Co-Authors: Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA

Multi-Institution Analysis of IMRT-based Re-Irradiation for Head and Neck Cancer: Prognostic Factors and Recursive Partitioning Analysis for Overall Survival

160 A/B/C

8:05 a.m.

Co-Authors: Caudell JJ, Ward MC, Koyfman S, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Awan MJ, Vargo J, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Trotti A, Siddiqui F, Lee N

Multi-Institution Analysis of Re-Irradiation for Head and Neck Cancer: Improved Risk-Benefit Profile in the IMRT Era

160 A/B/C

1:40 p.m.

Presenter: Ehsan Balagamwala, MD
Co-Author: Miller JA, Reddy CA, Angelov L, Suh JH, Tariq MB, Yang K, Djemil T, Magnelli A, Mohammadi AM, Soeder S, Chao ST

Recursive partitioning analysis is predictive of overall survival for patients undergoing spine radiosurgery for spine metastasis

206 A/B

2:20 p.m.

Co-Authors: Miller JA, Balagamwala EH, Berriochoa C, Angelov L, Suh JH, Tariq MB, Yang K, Magnelli A, Soeder S, Mohammadi AM, Djemil T, Benzel EC, Chao ST

Advertisement

The Impact of Instrumentation upon Local Control following Spine Stereotactic Radiosurgery

206 A/B

4:05 p.m.

Co-Authors: Miller JA, Kotecha R, Mohammadi AM, Murphy ES, Suh JH, Barnett GH, Vogelbaum MA, Angelov L, Ahluwalia MS, Chao ST

The Economic Implication of Upfront Whole-Brain Radiation Therapy for Patients with Limited Brain Metastasis

206 A/B

4:25 p.m.

Presenter: Bindu Manyam, MD
Co-Authors: Manyam BV, Garsa A, Chin RI, Reddy CA, Gastman B, Vidimos AT, Thorstad W, Yom S, Nussenbaum B, Wang S, Koyfman SA

A Multi-Institutional Comparison of Outcomes of Immunosuppressed and Immunocompetent Patients Treated with Surgery and Radiation Therapy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

104 A/B/C

ePoster

3:15 p.m.

Presenter: Ping Xia, PhD

Authors: Xia P, Yu N, Kolar M, Godley A, Chao S, Tendulkar R, Suh J

Quantitative Measures Improve Safety, Quality, Efficiency in Radiotherapy

Room: 052 A

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad